, Tracking Stock Market Picks
Enter Symbol:
Nxstage Medical, Inc. (NXTM) [hlAlert]

down 21.97 %

Nxstage Medical, Inc. (NXTM) downgraded to Underperform by Wells Fargo

Posted on: Tuesday,  Mar 11, 2014  8:25 AM ET by Wells Fargo

Wells Fargo rated Underperform Nxstage Medical, Inc. (NASDAQ: NXTM) on 03/11/2014, when the stock price was $13.81. Since
then, Nxstage Medical, Inc. has gained 28.17% as of 01/26/2016's recent price of $17.70.
If you would have followed this Wells Fargo's recommendation on NXTM, you would have lost 21.97% of your investment in 686 days.

NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure.

The investment research content is provided by Wells Capital Management, a registered investment adviser and wholly owned subsidiary of Wells Fargo Bank, N.A. Our economists’ expertise on domestic markets, and national and global trends, is an important resource to the firm. Wells Capital Management economists are known for their thoughts on investment strategy, macro-economic forecasts and other top-down analysis, and share their views on bonds, midcaps and liquidity management in their publications.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/11/2014 8:25 AM Sell
as of 10/17/2014
1 Week down  -5.25 %
1 Month down  -1.03 %
3 Months down  -0.81 %
1 YTD up  1.44 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/10/2012 8:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy